Tranexamic Acid
NDC 0591-3720, Tranexamic Acid, tablet, film coated, from Actavis Pharma, Inc..
- Product NDC
- 0591-3720
- Status
- Listed
- Labeler
- Actavis Pharma, Inc.
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA202093
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0591-3720 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TRANEXAMIC ACID650 mg/1
Pharmacologic classes
Antifibrinolytic Agent [EPC]; Decreased Fibrinolysis [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0591-3720-30 | 00591372030 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0591-3720-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/3f07e93b-3568-487e-894f-8f90e5a0960aNADAC price for package 00591372030
GET /v1/drugs/nadac/00591372030
Use it
Look up 0591-3720 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0591-3720 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0591-3720. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.